top of page

Our

Pipeline

Mechanism

Indication

Discovery

Candidate

Pre-clinical

Phase I

ACSS2 Inhibitor

Oncology

IDO/TDO Inhibitor

Oncology

CLK Inhibitor

Osteoarthritis

Chronic inflammation

STING Antagonist

Acute inflammation

Autoimmunity

HPK1 Inhibitor

Oncology

STING Agonist

Oncology

Vaccine Adjuvant

Actinic keratosis, warts

CRD3874-SI

bottom of page